Glycolysis genes, including the redox-dependent GAPDH step, showed consistent upregulation in HCC, whereas TXNIP, a key negative regulator of glucose uptake with a tumor suppressor function, showed striking downregulation (Fig. 2B and C; refs. 20, 21). This evidence concerns the gene TXNIP and hepatocellular carcinoma.